Enhanced expression of interleukin-6 in bone and serum of metastatic renal cell carcinoma

被引:18
作者
Paule, B
Clerc, D
Rudant, C
Coulombel, C
Bonhomme-Faivre, L
Quillard, J
Bisson, M
机构
[1] Hop Bicetre, Serv Rhumatol, F-94275 Le Kremlin Bicetre, France
[2] Univ Paris 05, UFR Biomed, UPR 37, F-75270 Paris, France
[3] Hop Paul Brousse, Dept Pharmacol, Serv Pharm, Villejuif, France
[4] Hop Bicetre, Serv Anatomopathol, F-94275 Le Kremlin Bicetre, France
关键词
interleukin-6; bone metastasis; renal cell carcinoma; immunohistochemistry;
D O I
10.1016/S0046-8177(98)90128-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Interleukin-6 (IL-6) is produced by renal cell carcinoma (RCC) cell lines and primary tumors. Using immunohistochemical staining in two RCC patients with hypercalcemia and high serum levels of free and total IL-6, we showed expression of IL-6 in metastatic bone tissue. The role of IL-6 in hypercalcemia and bone resorption would suggest that bisphosphonates or dexamethasone could be useful as adjuvant therapy for IL-6 dependant bone metastases which fail to respond to interferon alpha (IFN) alpha 2a and all trans retinoic acid (ATRA). Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:421 / 424
页数:4
相关论文
共 23 条
[1]  
BARILLE S, 1995, BLOOD, V86, P3151
[2]  
BERENSON JR, 1996, NEW ENGL J MED, V334, P448
[3]  
BLACK KS, 1990, J BONE MINER RES S2, V5, P787
[4]  
BLAY JY, 1992, CANCER RES, V52, P3317
[5]  
BLAY JY, 1994, P AACR, V35, P3357
[6]  
DUBOIS C, 1994, LEUKEMIA, V8, P1750
[7]   Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases [J].
Hortobagyi, GN ;
Theriault, RL ;
Porter, L ;
Blayney, D ;
Lipton, A ;
Sinoff, C ;
Wheeler, H ;
Simeone, JF ;
Seaman, J ;
Knight, RD ;
Heffernan, M ;
Reitsma, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24) :1785-1791
[8]   THE BIOLOGY OF INTERLEUKIN-6 [J].
KISHIMOTO, T .
BLOOD, 1989, 74 (01) :1-10
[9]  
KOO AS, 1990, SURG FORUM, V41, P710
[10]  
LICHTENSTEIN A, 1989, BLOOD, V74, P1266